medigraphic.com
ISSN 0035-0052 (Print)

2019, Number 3

<< Back Next >>

Rev Mex Pediatr 2019; 86 (3)

Acetaminophen versus ibuprofen for the closure of persistent arterial duct in preterm infants: systematic review and meta-analysis

Mora-Escallón D, Zapata-Ospina JP, González-Avendaño S

Language: Spanish
References: 28
Page: 94-103
PDF size: 291.47 Kb.


ABSTRACT

Objective: To compare the efficacy and safety of acetaminophen versus ibuprofen for the treatment of patent ductus arteriosus (PDA) in newborn preterm. Material and methods: Systematic review that included randomized clinical trials (RCTs) that compared the efficacy and safety for PDA closure in neonates, between acetaminophen and ibuprofen. RCTs were searched in electronic databases. The selection, data extraction and quality assessment of included studies were done independently by two reviewers. Results: Of 454 potential articles, six RCTs were selected. The sum of the six studies was 733 participants (n = 371 with acetaminophen and n = 362 with ibuprofen). The closure of PDA was similar between the two drugs (87.3% and 84.5%, respectively) so there was no statistical difference, RR = 1.04; CI95%: 0.99-1.09. For safety, in general, no differences were found in the variables studied with the exception that the incidence of gastrointestinal bleeding was lower with acetaminophen (RR = 0.28; 95% CI: 0.11-0.73). Conclusion: Acetaminophen orally is comparable in effectiveness to oral ibuprofen for PDA closure of preterm infants, with reduced risk of gastrointestinal bleeding.


REFERENCES

  1. Sellmer A, Bjerre JV, Schmidt MR, McNamara PJ, Hjortdal VE, Høst B et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child - Fetal Neonatal Ed. 2013; 98 (6): F505-510

  2. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006; 114(17): 1873-1882.

  3. Teixeira L, McNamara P. Enhanced intensive care for the neonatal ductus arteriosus. Acta Paediatr. 2006; 95 (4): 394-403. http://doi.wiley.com/10.1080/08035250500482271

  4. Evans N, Moorcraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child. 1992; 67 (10 Spec No): 1169-1173.

  5. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010; 30 (4): 241-252.

  6. DiMenna L, Laabs C, McCoskey L, Seals A. Management of the neonate with patent ductus arteriosus. J Perinat Neonatal Nurs. 2006; 20 (4): 333-340.

  7. Mercanti I, Boubred F, Simeoni U. Therapeutic closure of the ductus arteriosus: benefits and limitations. J Matern Fetal Neonatal Med. 2009; 22 Suppl 3: 14-20.

  8. Van Overmeire B. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus. Int J Clin Pract Suppl. 2003; Apr (135): 23-27.

  9. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011; 128 (6): e1618-e1621.

  10. Jasani B, Kabra N, Nanavati R. Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates. J Postgrad Med. 2013 (4): 312-314. doi: 10.4103/0022-3859.123164.

  11. Ozdemir OM, Doğan M, Küçüktaşçı K, Ergin H, Sahin O. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol. 2014; 35 (2): 276-279.

  12. Terrin G, Conte F, Scipione A, Bacchio E, Conti M, Ferro R et al. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr. 2014; 40 (1): 21. doi: 10.1186/1824-7288-40-21.

  13. Nadir E, Kassem E, Foldi S, Hochberg A, Feldman M. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol. 2014; 34(10): 748-749.

  14. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One [Internet]. 2013; 8(11): e77888.

  15. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr [Internet]. 2014; 164(3): 510-4.e1.

  16. Das R, Naik S, Arora K. Efficacy and safety of paracetamol versus ibuprofen for treating patent ductus arteriosus in preterm infants: a meta-analysis. J Clin Neonatol. 2014; 3(4): 183.

  17. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev. 2015 Mar 11;(3):CD010061. doi: 10.1002/14651858.CD010061.pub2.

  18. Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child - Fetal Neonatal Ed. 2016; 101(2): F127-F136.

  19. Centro Cochrane Iberoamericano T. Manual Cochrane de Revisiones Sistemáticas de Intervenciones, versión 5.1.0 [actualizada en marzo de 2011] [Internet]. Barcelona: Centro Cochrane Iberoamericano; 2012. Disponible en: http://www.cochrane.es/?q=es/node/269

  20. El-Mashad AER, El-Mahdy H, El Amrousy D, Elgendy M. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017; 176(2): 233-240.

  21. Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med. 2016 Sep 6.

  22. Habibi M, Nobakht M, Pirbazari TJ, Yazdi Z. The effect of oral ibuprofen and oral acetaminophen in the patent ductus arteriosus (PDA) in preterm infants born in Kouvsar Hospital of Qazvin (a comparative study). World J Pharm Med Res. 2016; 2(4): 203-237.

  23. Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bijari BB, Noroozi E et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr. 2016; 26(4): e3975.

  24. Hammerman C, Bin-Nun A, Kaplan M. Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol . 2012; 36 (2): 130-138.

  25. Santhanam S, Kumar M. Paracetamol in patent ductus arteriosus, “flavour of the month” or here to stay? Indian Pediatr. 2015; 52 (7): 567-568.

  26. Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Patent ductus arteriosus in preterm infants: do we have the right answers? Biomed Res Int. 2013; 2013: 1-15.

  27. Sivanandan S, Agarwal R. Pharmacological closure of patent ductus arteriosus: selecting the agent and route of administration. Pediatr Drugs. 2016; 18(2): 123-138.

  28. Ohlsson A1, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.Cochrane Database Syst Rev. 2015 Mar 11;(3):CD010061. doi: 10.1002/14651858.CD010061.pub2.




2020     |     www.medigraphic.com